FLUAD
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 23 Mar 2023)
What this means for you
Registered since 25 Oct 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86443221
- Registration number
- 5069225
- Mark type
- Stylized text
- Filed
- 03 Nov 2014
- Published for opposition
- 20 Jan 2015
- Registered
- 25 Oct 2016
- Attorney of record
- Nancy Sabarra
Goods and services
- Class 005 — Pharmaceuticals: Influenza vaccines for human use
Owner
- SEQIRUS UK LIMITED, Maidenhead, Berkshire, GB
- SEQIRUS UK LIMITED, Maidenhead, Berkshire, GB
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prior registrations
Prosecution history
- 26 Oct 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 23 Mar 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 23 Mar 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 23 Mar 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Sept 2022 — TEAS SECTION 8 & 15 RECEIVED
- 25 Oct 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 05 Apr 2017 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 31 Jan 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Oct 2016 — REGISTERED-PRINCIPAL REGISTER
- 29 Sept 2016 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 29 Sept 2016 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 29 Sept 2016 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Sept 2016 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 Sept 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
- 19 Sept 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED